Literature DB >> 15125787

Genetically modified animal models as tools for studying bone and mineral metabolism.

Rachel A Davey1, Helen E MacLean, Julie F McManus, David M Findlay, Jeffrey D Zajac.   

Abstract

Genetic modification of mice is a powerful tool for the study of bone development and metabolism. This review discusses the advantages and disadvantages of various approaches used in bone-related research and the contributions these studies have made to bone biology. Genetic modification of mice is a powerful tool for the study of bone development and metabolism. This review discusses the advantages and disadvantages of various approaches used in bone-related research and the contributions these studies have made to bone biology. The approaches to genetic modification included in this review are (1) overexpression of genes, (2) global gene knockouts, (3) tissue-specific gene deletion, and (4) gene knock-in models. This review also highlights issues that should be considered when using genetically modified animal models, including the rigorous control of genetic background, use of appropriate control lines, and confirmation of tissue specificity of gene expression where appropriate. This technology provides a unique and powerful way to probe the function of genes and is already revolutionizing our approach to understanding the physiology of bone development and metabolism. Copyright 2004 American Society for Bone and Mineral Research

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15125787     DOI: 10.1359/JBMR.040206

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  9 in total

1.  Human stanniocalcin-1 or -2 expressed in mice reduces bone size and severely inhibits cranial intramembranous bone growth.

Authors:  Jennifer Johnston; Yudith Ramos-Valdes; Lee-Anne Stanton; Sadia Ladhani; Frank Beier; Gabriel E Dimattia
Journal:  Transgenic Res       Date:  2010-02-20       Impact factor: 2.788

Review 2.  Androgen Receptor Structure, Function and Biology: From Bench to Bedside.

Authors:  Rachel A Davey; Mathis Grossmann
Journal:  Clin Biochem Rev       Date:  2016-02

3.  In vivo delivery of fluoresceinated dextrans to the murine growth plate: imaging of three vascular routes by multiphoton microscopy.

Authors:  Cornelia E Farnum; Michelle Lenox; Warren Zipfel; William Horton; Rebecca Williams
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2006-01

4.  Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice.

Authors:  Rachel A Davey; Andrew G Turner; Julie F McManus; W S Maria Chiu; Francisca Tjahyono; Alison J Moore; Gerald J Atkins; Paul H Anderson; Cathy Ma; Vaida Glatt; Helen E MacLean; Cristina Vincent; Mary Bouxsein; Howard A Morris; David M Findlay; Jeffrey D Zajac
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

5.  The elevated expression of calcitonin receptor by cells recruited into the endothelial layer and neo-intima of atherosclerotic plaque.

Authors:  Peter J Wookey; Anthony Zulli; David L Hare
Journal:  Histochem Cell Biol       Date:  2009-04-29       Impact factor: 4.304

6.  GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice.

Authors:  Jeffery Ford; Asghar Hajibeigi; Michael Long; Lisa Hahner; Crystal Gore; Jer-Tseng Hsieh; Deborah Clegg; Joseph Zerwekh; Orhan K Oz
Journal:  J Bone Miner Res       Date:  2011-02       Impact factor: 6.741

Review 7.  Human androgen deficiency: insights gained from androgen receptor knockout mouse models.

Authors:  Kesha Rana; Rachel A Davey; Jeffrey D Zajac
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

8.  Inbred strain-specific response to biglycan deficiency in the cortical bone of C57BL6/129 and C3H/He mice.

Authors:  Joseph M Wallace; Kurtulus Golcuk; Michael D Morris; David H Kohn
Journal:  J Bone Miner Res       Date:  2009-06       Impact factor: 6.741

9.  Low-dose TNF augments fracture healing in normal and osteoporotic bone by up-regulating the innate immune response.

Authors:  James K Chan; Graeme E Glass; Adel Ersek; Andrew Freidin; Garry A Williams; Kate Gowers; Ana I Espirito Santo; Rosemary Jeffery; William R Otto; Richard Poulsom; Marc Feldmann; Sara M Rankin; Nicole J Horwood; Jagdeep Nanchahal
Journal:  EMBO Mol Med       Date:  2015-05       Impact factor: 14.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.